Additionally, we previously demonstrated that combinatorial treatment with metformin and pembrolizumab enhanced anti-tumor immunity in STK11 mutant lung cancer via axis inhibition protein 1 (AXIN1)-dependent inhibition of STING ubiquitination [16]. The gene discussed is STK11; the disease is lung carcinoma.